Our Phase II & III Capabilities

Many of our sites have participated in research for 10+ years. Our partnerships provide access to CA residents throughout the State with nearly 20 partnerships in over 50+ locations. We help provide access to a diverse patient population, including minority groups that otherwise go unrepresented in research. 

Rapid Start

  • Central IRB.
  • Contract and budget response within 48 hours.
  • Regulatory documents completed in parallel.
  • Often able to complete start-up within 2 weeks.
  • Dedicated Call Center team to assist with enrolling.

Capabilities

  • FibroScans, ultrasounds, X-rays, PBMC, local labs, and much more available at many locations. 
  • Nearby access to liver biopsy, MRI-PDFF, DEXA, CT-Scans, and much more.  
  • Efficient prescreening process.
  • Experience with telemedicine, virtual, and hybrid trials.

Quality Control

  • Our Internal quality team provides QC on all ICF and critical documents.
  • eRegulatory and eSource offer increased quality and efficiency.
  • eDocuments available for sponsor review 24/7.

Our Diverse Data

Race/Ethnicity

US Census (%)

(2019)

US Patients (%) in Clinical Trials

FOMAT Enrollment

(%)

White / Caucasian

76.5

84.2

36%

Black/African-American

13.4

7.3

1%

Asian

5.9

3.4

5%

Native Hawaiian/ Pacific Islander

0.2

0.1

0.3%

Native-Indian/Native Alaskan

1.3

0.1

0.3%

More than 1 race

2.7

0.0

3%

Other/Unknown

-

3.7

7.4%

Hispanic/Latino

18.3

2.8

47%